{"ticker": {"uuid": "95def50f-c78f-4cc2-9794-e66d3b39f20d", "symbol": "OXB", "name": "Oxford Biomedica plc", "exchange": "LSE", "country": "GB", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "REG - Oxford Biomedica PLC M&G PLC - Holding(s) in Company", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOZE52cTMzMlJNb0trckJWWUNEMkxIS3FUVEx3UGVkRG9LYkl2N0NTYkw1czVDeUxha2o4N3R6SjlVZ2tpNEdBN0M2M1Q3R3YtR3N6aGwtQWtEbnc5X1lTMUZ4NEk4Z2tLM0I4X1pyQ0p4TFRPV2s2aTJrcEpXdEtPOWZTcnRIcURPaFV1dmN4VFN6T2hyR3Eycy1Sb09SYTBIUFZGdkNEeDZsWHVsaFZISnJ6VG9CN2hCbkgzeXlxcWVMLUdMTFhrWQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-14T13:45:34+00:00", "published_display": "14 Jul 2026 13:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - Oxford Biomedica PLC - Admission to Trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPUVNXVmxHd0hZT0Q0cWJoc1Jld2syalFmSThjdlVOOE1CQU1oYWtTMmkyN3FSSW9xOGNGeGF1dEVmeG5BSEUxWlR5NWpYN3FGREk4NWJSWlpOcHpNT3R3d2x5dFhHTmtmRmptUzM4T0NwN1RRMTQzanJXcDZZMlJVR2hYcHFFZFNIbVJoTm9UTmQ5bDN1YTlPbmNRd1ZpLW8tcTRPZWJZVWtxMzB2em9OMWFMQ0JDMmM2eWgyUHhn?oc=5", "source_name": "TradingView", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - Oxford Biomedica PLC - Admission to trading application", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNRGVMSXVzbGlrdHZkTnQ5UkR5eEthSDdTUEIyZHR6R3FHQTVTZm5hQTk1MEhvTlItNl8zb1ZyRm1CQVNBZjlVZkp3dGxtSWhqUl9rYm1HWFozMG1IQWI2N0JWNW96aEJjS01aWGtwY0pOSE1OQm9oSEJuajBjVzRPZlhtaDBiMVRxSFZUNzc3MWstZnJuS0xvUkw2SldsU2g0THFkc3c2ZkFXckN2N2lURG8tR1Q2SW5TWEc3Z2lmWHc3TEUtSldsMEJzZEVhQQ?oc=5", "source_name": "TradingView", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oxford BioMedica leaves door open to private equity takeover", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPZ185SlltcUQ3elg4eUxGTjAzZ2lQVC1uYVZSZlcxTHNmQmZpem5GQWt0Q3dXM3M3eVozdTgyeUFRbzBKR3VKQVR1bXJLNFRrQ2R0bVVVSXFNUHl4NFZabGZVa1VQYnN4UGc3MVg1bUE4QU9MR0wyVjFMN09EM1VkSllhQWo?oc=5", "source_name": "Financial Times", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Oxford Biomedica (LSE:OXB) Is Reframing Its Long Term Value Story Around \u00a38.43", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOWDZQNDYxSnA0aWJtbGpEVTFMNy1VbEo1d3BSSkJub0d5TEtfMFBDRVZTYzNkM2NFUFlLTjcxdXNTT1NpVzFUUGZ0a2stWUEwbHZUM1FFbUpWNUtWRXpRTjNib0J1Vm1uRU43Xy1mbkN3djBWQWc1NzRER0Q2OENtRkMzeHZDekZQMHFLbzZEZjBCSm9wZHFCWDZMR2xwSDBL?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oxford Bio expects solid revenue growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNb3ZBTnZyaXhSYXB0MFdMaVJQYlVjcXhTSVJ6RXotR0RRdC1pMDBtUWlRZUZQZHJOdzNWdHd4aml4R3pLSzEwRzRKVEpidk4zdW5JS1d5SE0zRUl3b2pRU1lBTGVaOEtXRllCQmlqMTVkeVYySF9CY2txcjVaYXN1TW5Dd3pmSUVS?oc=5", "source_name": "Investors' Chronicle", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQT backs out of takeover bid for UK's Oxford Biomedica", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOQTNJU1JsdDA1RFNsQVdtV1BxeUhpSlFQU1JzeEJYS2lCcVBRSmdhS2w2MTV2Wl9CSWxRRG9rNkFGbUZZMU5NNnotUVFCeWdZVFdQLXN5RVNEVGJvSXFpeVpGT2gtUTNVaDdqUTdIUnNSMXVKa1Y0ZmtEZUpfMEIteUk0eWZpQ3htcFZNQUIyVXdsaE4tbXVTU0RraE5WZU9Qc1Z6bmhjR3kzcmNJSEJQbi1yd1dUdFMxLS1N?oc=5", "source_name": "Reuters", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oxford Biomedica trading update ignored as bid deadline looms", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPcVdBX2JQQXdYRUxkeXlYeW1fR0swQTVvdFFVM2xZaU1Jc19DNHJMLVlod016WThwbGhQZk5jeURhSzdIQU00bTFsMFhETjdzbUxjVklYZk9aNHZ1Ykdwa2k3ZWp4dDluWW5UZHNia2J2clRPejFqcVdLM05mYXhDX21WQmQtdTZpczlINl95dDRnNkFuQXpuTlNFRlRHSERBSjFHdGFzcUpHOUZxUFg2QU5mUC0xXzhGT0VCeU1qWXZwd3pmdi1GcFZEU2ZNMGc?oc=5", "source_name": "Proactive Investors", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oxford Innotech Berhad's (KLSE:OXB) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oxford Biomedica share prices jumps after takeover talks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQRV9scU1XanltOEJKUndIazdVY0ZkVHdLdEdsVXBMaEV4UzdtclRkYU51eDBFZ2d6RU41NXEwUlliTk10cG1XZ01teDU1aFJXZklPU05JY29XZDVoa09PalRoQUVya1BaeG8zMGhXaEZRTHFZUlFLQURCWnNRbUtjUjJTQVFtYXM?oc=5", "source_name": "City AM", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQT in talks to take over Oxford BioMedica", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOc0JYWkxaOEl2SmRqdFhGbjZlTFNfZzRRVnpaQmJfQlhKS2h4Y2tCRjQ5aTBZOVV0SlhXUHNoX3oyUFNpeXh4eGJmQWlaZl9nTWMyUm45TmtDRDQzYjZlekhlbDliWk1qUmxnR3NVeTFESGpqSW9ielN4TDV0ZHVQT1J2VUI?oc=5", "source_name": "Financial Times", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQT Funds Make Unsolicited Offer for Oxford Biomedica Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQMjJEVGZsamxXX0diaXdxMHRFXzdvUjJ1TFA5T3YtaFdSMEhOcDZFUW1HUVdMcllRc28tUURkS3lJUzFyYzRoWlZFTlNQSHBDcVZCdEluRmFpSlYyaWVxN3I2ODFHdld6VUx6cy1xLWdvcVQ3Yjk4aENseWFVd0w1VFE1WWdtMlg1alFkYXdvTks1SWJHRlBRTFppT0xYWU5QRmc?oc=5", "source_name": "Global Banking & Finance Review", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Revenues Working Against Oxford Biomedica plc's (LON:OXB) Share Price", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-30T08:00:00+00:00", "published_display": "30 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oxford Biomedica plc (LON:OXB): Is Breakeven Near?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-30T07:00:00+00:00", "published_display": "30 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oxford Biomedica ramps up production", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPeEx3N1NhWFV5TGJoZGVRc25TUWplSVh1aDZMMm5PbC1aOC1qUlR6SmZGdXNVMnN3ZVl2dVNoMkt5MmQyUTJyU3V6YkJFd2RHeE5henUxeFZBME8tZHJEMVdDb1Jrc3FveTdCR2wweGxuLUdaY2NseTFkSXNGQWN2WENzMFZiNDk1?oc=5", "source_name": "Investors' Chronicle", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "White & Case advises on Oxford Biomedica equity placing", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOaDNwMmVVNGE0MWNEOEkwTU5Ia2l0d2RRd0lXa2pkWEtlbDdTUks4blZZbmFvTjU0ZEJIeWFaWC1iS3dWcVNrSV8yYjRoRXFOQlBXeV9FbzNEc25LcGRucXZseUgyQ3FHY3ZkaDNkR0pCQ2JROVBCRk40UGktWllvaVB4bzUyTTlDZXRvX2JNenJ4OEIxcl83RERhcw?oc=5", "source_name": "White & Case LLP", "published_at": "2025-08-15T07:00:00+00:00", "published_display": "15 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "REG - Oxford Biomedica PLC M&G PLC - Holding(s) in Company", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOZE52cTMzMlJNb0trckJWWUNEMkxIS3FUVEx3UGVkRG9LYkl2N0NTYkw1czVDeUxha2o4N3R6SjlVZ2tpNEdBN0M2M1Q3R3YtR3N6aGwtQWtEbnc5X1lTMUZ4NEk4Z2tLM0I4X1pyQ0p4TFRPV2s2aTJrcEpXdEtPOWZTcnRIcURPaFV1dmN4VFN6T2hyR3Eycy1Sb09SYTBIUFZGdkNEeDZsWHVsaFZISnJ6VG9CN2hCbkgzeXlxcWVMLUdMTFhrWQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-14T13:45:34+00:00", "published_display": "14 Jul 2026 13:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - Oxford Biomedica PLC - Admission to Trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPUVNXVmxHd0hZT0Q0cWJoc1Jld2syalFmSThjdlVOOE1CQU1oYWtTMmkyN3FSSW9xOGNGeGF1dEVmeG5BSEUxWlR5NWpYN3FGREk4NWJSWlpOcHpNT3R3d2x5dFhHTmtmRmptUzM4T0NwN1RRMTQzanJXcDZZMlJVR2hYcHFFZFNIbVJoTm9UTmQ5bDN1YTlPbmNRd1ZpLW8tcTRPZWJZVWtxMzB2em9OMWFMQ0JDMmM2eWgyUHhn?oc=5", "source_name": "TradingView", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - Oxford Biomedica PLC - Admission to trading application", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNRGVMSXVzbGlrdHZkTnQ5UkR5eEthSDdTUEIyZHR6R3FHQTVTZm5hQTk1MEhvTlItNl8zb1ZyRm1CQVNBZjlVZkp3dGxtSWhqUl9rYm1HWFozMG1IQWI2N0JWNW96aEJjS01aWGtwY0pOSE1OQm9oSEJuajBjVzRPZlhtaDBiMVRxSFZUNzc3MWstZnJuS0xvUkw2SldsU2g0THFkc3c2ZkFXckN2N2lURG8tR1Q2SW5TWEc3Z2lmWHc3TEUtSldsMEJzZEVhQQ?oc=5", "source_name": "TradingView", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oxford BioMedica leaves door open to private equity takeover", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPZ185SlltcUQ3elg4eUxGTjAzZ2lQVC1uYVZSZlcxTHNmQmZpem5GQWt0Q3dXM3M3eVozdTgyeUFRbzBKR3VKQVR1bXJLNFRrQ2R0bVVVSXFNUHl4NFZabGZVa1VQYnN4UGc3MVg1bUE4QU9MR0wyVjFMN09EM1VkSllhQWo?oc=5", "source_name": "Financial Times", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Oxford Biomedica (LSE:OXB) Is Reframing Its Long Term Value Story Around \u00a38.43", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOWDZQNDYxSnA0aWJtbGpEVTFMNy1VbEo1d3BSSkJub0d5TEtfMFBDRVZTYzNkM2NFUFlLTjcxdXNTT1NpVzFUUGZ0a2stWUEwbHZUM1FFbUpWNUtWRXpRTjNib0J1Vm1uRU43Xy1mbkN3djBWQWc1NzRER0Q2OENtRkMzeHZDekZQMHFLbzZEZjBCSm9wZHFCWDZMR2xwSDBL?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oxford Bio expects solid revenue growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNb3ZBTnZyaXhSYXB0MFdMaVJQYlVjcXhTSVJ6RXotR0RRdC1pMDBtUWlRZUZQZHJOdzNWdHd4aml4R3pLSzEwRzRKVEpidk4zdW5JS1d5SE0zRUl3b2pRU1lBTGVaOEtXRllCQmlqMTVkeVYySF9CY2txcjVaYXN1TW5Dd3pmSUVS?oc=5", "source_name": "Investors' Chronicle", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQT backs out of takeover bid for UK's Oxford Biomedica", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOQTNJU1JsdDA1RFNsQVdtV1BxeUhpSlFQU1JzeEJYS2lCcVBRSmdhS2w2MTV2Wl9CSWxRRG9rNkFGbUZZMU5NNnotUVFCeWdZVFdQLXN5RVNEVGJvSXFpeVpGT2gtUTNVaDdqUTdIUnNSMXVKa1Y0ZmtEZUpfMEIteUk0eWZpQ3htcFZNQUIyVXdsaE4tbXVTU0RraE5WZU9Qc1Z6bmhjR3kzcmNJSEJQbi1yd1dUdFMxLS1N?oc=5", "source_name": "Reuters", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oxford Biomedica trading update ignored as bid deadline looms", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPcVdBX2JQQXdYRUxkeXlYeW1fR0swQTVvdFFVM2xZaU1Jc19DNHJMLVlod016WThwbGhQZk5jeURhSzdIQU00bTFsMFhETjdzbUxjVklYZk9aNHZ1Ykdwa2k3ZWp4dDluWW5UZHNia2J2clRPejFqcVdLM05mYXhDX21WQmQtdTZpczlINl95dDRnNkFuQXpuTlNFRlRHSERBSjFHdGFzcUpHOUZxUFg2QU5mUC0xXzhGT0VCeU1qWXZwd3pmdi1GcFZEU2ZNMGc?oc=5", "source_name": "Proactive Investors", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oxford Innotech Berhad's (KLSE:OXB) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oxford Biomedica share prices jumps after takeover talks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQRV9scU1XanltOEJKUndIazdVY0ZkVHdLdEdsVXBMaEV4UzdtclRkYU51eDBFZ2d6RU41NXEwUlliTk10cG1XZ01teDU1aFJXZklPU05JY29XZDVoa09PalRoQUVya1BaeG8zMGhXaEZRTHFZUlFLQURCWnNRbUtjUjJTQVFtYXM?oc=5", "source_name": "City AM", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQT in talks to take over Oxford BioMedica", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOc0JYWkxaOEl2SmRqdFhGbjZlTFNfZzRRVnpaQmJfQlhKS2h4Y2tCRjQ5aTBZOVV0SlhXUHNoX3oyUFNpeXh4eGJmQWlaZl9nTWMyUm45TmtDRDQzYjZlekhlbDliWk1qUmxnR3NVeTFESGpqSW9ielN4TDV0ZHVQT1J2VUI?oc=5", "source_name": "Financial Times", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EQT Funds Make Unsolicited Offer for Oxford Biomedica Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQMjJEVGZsamxXX0diaXdxMHRFXzdvUjJ1TFA5T3YtaFdSMEhOcDZFUW1HUVdMcllRc28tUURkS3lJUzFyYzRoWlZFTlNQSHBDcVZCdEluRmFpSlYyaWVxN3I2ODFHdld6VUx6cy1xLWdvcVQ3Yjk4aENseWFVd0w1VFE1WWdtMlg1alFkYXdvTks1SWJHRlBRTFppT0xYWU5QRmc?oc=5", "source_name": "Global Banking & Finance Review", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Revenues Working Against Oxford Biomedica plc's (LON:OXB) Share Price", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-30T08:00:00+00:00", "published_display": "30 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oxford Biomedica plc (LON:OXB): Is Breakeven Near?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-30T07:00:00+00:00", "published_display": "30 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oxford Biomedica ramps up production", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPeEx3N1NhWFV5TGJoZGVRc25TUWplSVh1aDZMMm5PbC1aOC1qUlR6SmZGdXNVMnN3ZVl2dVNoMkt5MmQyUTJyU3V6YkJFd2RHeE5henUxeFZBME8tZHJEMVdDb1Jrc3FveTdCR2wweGxuLUdaY2NseTFkSXNGQWN2WENzMFZiNDk1?oc=5", "source_name": "Investors' Chronicle", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "White & Case advises on Oxford Biomedica equity placing", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOaDNwMmVVNGE0MWNEOEkwTU5Ia2l0d2RRd0lXa2pkWEtlbDdTUks4blZZbmFvTjU0ZEJIeWFaWC1iS3dWcVNrSV8yYjRoRXFOQlBXeV9FbzNEc25LcGRucXZseUgyQ3FHY3ZkaDNkR0pCQ2JROVBCRk40UGktWllvaVB4bzUyTTlDZXRvX2JNenJ4OEIxcl83RERhcw?oc=5", "source_name": "White & Case LLP", "published_at": "2025-08-15T07:00:00+00:00", "published_display": "15 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 85, "total_relevant": 16, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 14, "score": 52, "total": 16, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 93, "events": [{"event": "general", "label": "Market update", "weight": 9.3, "count": 15}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 611.0, "latest_week": "2026-07-10", "one_week_move": -1.3, "four_week_move": 1.8, "twelve_week_move": -4.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.470304, "market_dynamics_buy_signal": false, "relative_strength": -6.545489, "fair_value_gap": 48.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 44.4153, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.3% over one week, +1.8% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "Financial Times", "count": 2}, {"label": "Investors' Chronicle", "count": 2}, {"label": "Market source", "count": 1}, {"label": "Reuters", "count": 1}, {"label": "Proactive Investors", "count": 1}, {"label": "City AM", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 16}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 15}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "93/100 classification confidence."}, {"label": "Company focus", "value": "16", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.3% over one week, +1.8% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "REG - Oxford Biomedica PLC M&G PLC - Holding(s) in Company"}], "updated_at": "2026-07-17T06:11:20.785959+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}